| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.45 | 1e-21 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.35 | 2e-14 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-12 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.31 | 4e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.29 | 8e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |